Abstract
MULTIPLE sclerosis is thought to be an autoimmune disease of the central nervous system mediated by T cells specific for a myelin antigen1,2. Myelin basic protein has been studied as a potential autoantigen in the disease because of its role as an encephalitogen in experimental autoimmune encephalomyelitis and post-viral encephalomyelitis3,4 and because of the presence in the blood of multiple sclerosis patients of in vivo-activated T cells reactive to myelin basic protein5. Immune involvement in multiple sclerosis has been further suggested by the association with the major histocompatibility complex class II phenotype DR2, DQwl (refs 6–9). To define the T-cell specificity toward myelin basic protein, 15,824 short-term T-cell lines were established from multiple sclerosis subjects, subjects with other neurological diseases, and normal controls. Here we report a higher frequency of T-cell lines reactive with a DR2-associated region of myelin basic protein between residues 84–102 in patients with multiple sclerosis compared with controls. A second region, identified between residues 143–168, was recognized equally in multiple sclerosis patients and controls and was associated with the DRwll phenotype. These DR2 and DRw11 associations were also observed among T-cell lines generated from family members of a multiple sclerosis patient. The immunodominant 84–102 peptide from myelin basic protein was both DR2- and DQwl-restricted among different T-cell lines. These results raise the possibility that this immunodominant region may be encephalitogenic in some DR2+ individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McFarlin, D. E. & McFarland, H. F. New Eng. J. Med. 307, 1183–1188 (1982).
Hafler, D. A. & Weiner, H. L. Immun. Today 10, 104–107 (1989).
Alvord, E. C., Kies, M. W. & Suckling A. J. (eds) in Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis (Liss, New York, 1984).
Hafler, D. A., Benjamin, D. S., Burks, J. & Weiner, H. L. J. Immun. 139, 68–72 (1987).
Allegretta, M., Nicklas, J. A., Sriram, S. & Albertini, R. J. Science 247, 718–721 (1990).
Ho, H.-Z., Tiwari, J. L., Haile, R. W., Terasaki, P. I. & Morton, N. E. Immunogenetics 15, 509–517 (1981).
Spielman, R. S. & Nathenson, N. Epidemol. Rev. 4, 45–65 (1982).
Francis, D. A., Batchelor, J. R., McDonald, W. I., Hern, J. E. C. & Downie, A. W. Lancet i, 211 (1986).
Elian, M. et al. Disease Markers 5, 89–99 (1987).
Brinkman, C. J. J. et al. Ann. Neurol. 11, 450–455 (1981).
Johnson, D. et al. J. Neuroimmun. 13, 99–108 (1986).
Brod, S. A., Purvee, M., Benjamin, D. & Hafler, D. A. Cell. Immun. 125, 426–436 (1990).
Waksman, B. H., Porter, H., Lees, M. B., Adams, R. D. & Folch, J. J. exp. Med. 100, 451–471 (1954).
Yoshimura, T. et al. J. neurol. Sci. 69, 47–58 (1985).
Baxevanis, C. N. et al. J. Neuroimmun. 22, 23–30 (1989).
Antel, J. P., Arnason, B. G. W. & Medof, M. E. Ann. Neurol. 5, 338–342 (1979).
Chofflon, M., Weiner, H. L., Morimoto, C. & Hafler, D. A. Ann. Neurol. 24, 185–191 (1988).
Zamvil, S. et al. Nature 324, 258–260 (1986).
Sakai, K. et al. J. Neuroimmun. 19, 21–32 (1988).
Happ, M. P., Wettstein, P., Dietzschold, B. & Heber-Katz, E. J. Immun. 141, 1489–1494 (1988).
Offner, H. et al. J. exp. Med. 170, 355–367 (1989).
Vandenbark, A. A. et al. J. Immun. 135, 229–233 (1985).
Schluesener, H. J. & Wekerle, H. J. Immun. 135, 3128–3133 (1985).
Chou, F. C.-H., Chou, C.-J. J., Shapira, R. & Kibler, R. F. J. biol. Chem. 251, 2671–2679 (1976).
Dupont, B. (ed) in Immunobiology of HLA (Springer, New York, 1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ota, K., Matsui, M., Milford, E. et al. T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183–187 (1990). https://doi.org/10.1038/346183a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/346183a0
This article is cited by
-
Antigen-presenting innate lymphoid cells orchestrate neuroinflammation
Nature (2021)
-
Viral mouse models used to study multiple sclerosis: past and present
Archives of Virology (2021)
-
Multiple sclerosis enters a grey area
Nature (2019)
-
Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis
Genes & Immunity (2019)
-
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Nature (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.